BARCLAYS PLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$892
-26.0%
53,651
-16.7%
0.00%0.0%
Q2 2023$1,205
+31.4%
64,436
+28.8%
0.00%
Q1 2023$917
-41.9%
50,034
-37.2%
0.00%
-100.0%
Q4 2022$1,577
-99.9%
79,652
+76.9%
0.00%0.0%
Q3 2022$1,084,000
+2158.3%
45,026
+1610.7%
0.00%
Q2 2022$48,000
-91.7%
2,632
-90.0%
0.00%
Q1 2022$580,00026,3700.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders